General procedure for the HF elimination of 3a-c. A solution of 7 (8,9 mmol) in THF (20 mL) was cooled to −78 °C under argon. Subsequently, a solution of n-BuLi (1.6 M in hexanes, 11.6 mL, 18,6 mmol) was added dropwise and the solution was stirred for 30 min at −78 °C. The reaction mixture was allowed warm up to −20 °C, and a 1:1 mixture of H 2 O:THF (2 mL) was then added. The mixture was warmed up to rt and partitioned between H 2 O (10 mL) and CH 2 Cl 2 (100 mL). The organic phase was separated, dried (MgSO 4 ), and concentrated under vacuum. The residue was purified by column chromatography over silica gel (CH 2 Cl 2 ) to afford the corresponding alkylated difluoroalkenes 5a-c. General procedure for the [3+2] cycloaddition. At 0 °C, TMSOTf (222 mg, 1 mmol) was added dropwise to a mixture of nitrone 8 or heterodiene 10 (1 mmol) and alkene 3 (1 mmol) in chloroform. At the end of the addition, the reaction mixture was allowed to warm up to rt, stirred during the indicated period of time, and then, diluted with CH 2 Cl 2 (25 mL) and neutralized with a saturated aqueous solution of NaHCO 3 (10 mL). After drying over MgSO 4 , the solvent was removed and the crude product was purified by flash column chromatography on silica gel (cyclohexane-diethyl ether 1:1) to afford the corresponding adducts. Ethyl 2-benzyl-4,4-difluoro-5-(2-oxooxazolidin-3-yl)isoxazolidine-3-carboxylate 9a. After the general procedure. The crude mixture was purified by column chromatography to afford 2 fractions: F1 (cis-9a, 48%) and F2 (trans-9a, 43%) as colorless oil. cis-Ethyl 2-benzyl-4,4-difluoro-5-(2-oxooxazolidin-3-yl)isoxazolidine-3-carboxylate cis9a.
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